DexCom, Inc. (DXCM)

NASDAQ: DXCM · IEX Real-Time Price · USD
121.74
+6.67 (5.80%)
At close: Mar 1, 2024, 4:00 PM
121.50
-0.24 (-0.20%)
After-hours: Mar 1, 2024, 7:58 PM EST
5.80%
Market Cap 46.93B
Revenue (ttm) 3.62B
Net Income (ttm) 541.50M
Shares Out 385.52M
EPS (ttm) 1.30
PE Ratio 93.65
Forward PE 68.70
Dividend n/a
Ex-Dividend Date n/a
Volume 4,530,844
Open 114.37
Previous Close 115.07
Day's Range 113.69 - 122.23
52-Week Range 74.75 - 139.55
Beta 1.20
Analysts Strong Buy
Price Target 136.15 (+11.84%)
Earnings Date Apr 25, 2024

About DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into t... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Apr 14, 2005
Employees 9,600
Stock Exchange NASDAQ
Ticker Symbol DXCM
Full Company Profile

Financial Performance

In 2023, DexCom's revenue was $3.62 billion, an increase of 24.49% compared to the previous year's $2.91 billion. Earnings were $541.50 million, an increase of 58.70%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for DXCM stock is "Strong Buy." The 12-month stock price forecast is $136.15, which is an increase of 11.84% from the latest price.

Price Target
$136.15
(11.84% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual R...

5 days ago - Business Wire

Tiger Global slashes stakes in Magnificent Seven while piling into semiconductor makers

Tiger Global has slashed its positions in four of the five Magnificent Seven tech stocks that account for almost half of its portfolio, while upping its stake in Amazon.com and piling into semiconduct...

17 days ago - Market Watch

Wall Street is surprisingly most bullish on these 3 Nasdaq stocks

NVIDIA is the best example. After soaring 239% last year, the semiconductor leader is up almost 50% year-to-date.

18 days ago - MarketBeat

Dexcom beats profit estimates on strong demand for glucose monitors

Glucose monitor maker Dexcom beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems.

24 days ago - Reuters

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #DXCM--Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results.

24 days ago - Business Wire

3 Nasdaq stocks likely to make big earnings splashes

The widely followed Nasdaq-100 index is up 13 of the last 14 weeks, a huge move that dates back to Halloween. Booming artificial intelligence plays and hopes of multiple Fed rate cuts this year have p...

Other symbols: DASHMELI
25 days ago - MarketBeat

Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of ...

26 days ago - Business Wire

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2023 financial results after market close on Thursday, February 8, 20...

5 weeks ago - Business Wire

Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

GALWAY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, has officially broken ground on its new stat...

6 weeks ago - Business Wire

Charts turn bullish on health-care stocks as sector takes early lead in 2024

Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h...

6 weeks ago - Market Watch

A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose...

6 weeks ago - Business Wire

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #Dexcom--Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook.

7 weeks ago - Business Wire

3 Medical-Device Stocks Could Click in 2024

Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales.

Other symbols: BSXPODD
2 months ago - Barrons

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 42nd annual J.P. ...

2 months ago - Business Wire

Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitor...

3 months ago - Business Wire

'Ten-bagger' stocks are the 'holy grail': Strategist

As Wall Street weighs whether markets can sustain November's rally, investors are spotting opportunities. eToro Global Markets Strategist Ben Laidler joined Yahoo Finance Live to analyze high-growth "...

3 months ago - Yahoo Finance

Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitor...

3 months ago - Business Wire

DexCom CF0: GLP-1s and continuous glucose monitoring are companion therapies

Jereme Sylvain, CFO at DexCom joins Bloomberg Radio to discuss DexCom's earnings and financial outlook. -------- Get more on The Tape Podcast On Apple: http://bit.ly/3YrBfOi On Spotify: http://bit.ly/...

3 months ago - Bloomberg Markets and Finance

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

SAN DIEGO & EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) systems for people with diabetes, is teaming up with D...

3 months ago - Business Wire

Earnings-season winners: 20 companies that have grown sales while improving profit margins

Earnings season is a time when investors like to see a “beat and raise” pattern. That is, companies report sales and earnings that surprise the market by coming in ahead of analysts' estimates.

4 months ago - Market Watch

Dexcom stock climbs as worries surrounding weight-loss drugs fades

CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector.

4 months ago - CNBC Television

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.

4 months ago - Barrons

Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say

Diabetes-device makers' stocks are breaking out of ‘GLP-1 jail' ahead of schedule, analysts say, after months of stock-market punishment based on fears that the popular obesity drugs would clobber the...

Other symbols: NVOPODDTNDM
4 months ago - Market Watch

Glucose monitor maker DexCom's stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows

Shares of DexCom Inc. DXCM, -3.86% shot up 15.3% to pace the S&P 500's SPX, -1.18% after-hours gainers on Thursday, after of maker of glucose monitoring systems reported third-quarter profit that beat...

4 months ago - Market Watch

Dexcom lifts 2023 revenue view on strong demand for diabetes devices

Medical device maker Dexcom on Thursday raised its annual revenue forecast and beat quarterly estimates on strong demand for its continuous glucose monitoring (CGM) devices, sending its shares more th...

4 months ago - Reuters